CWG
PRCT icon

C WorldWide Group’s Procept Biorobotics PRCT Stock Holding History

C WorldWide Group’s Portfolio PRCT Stock Details PRCT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$8.47M Hold
375,000
– – 0.2% 63
2026
Q1 		$9.38M Hold
375,000
– – 0.2% 59
2025
Q4 		$11.8M Buy
375,000
+225,000
+150% +$7.46M 0.21% 55
2025
Q3 		$5.35M Buy
+150,000
New +$6.85M 0.08% 71

Other funds holding PRCT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
BNP Paribas Asset Management
BNP Paribas Asset Management Paris, France $99.8B AUM 45.22% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
CC
Chicago Capital Chicago, Illinois $4.15B AUM 31.09% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return

C WorldWide Group's PRCT Position: Q2 2026 in Review

C WorldWide Group held its Procept Biorobotics (PRCT) position steady in Q2 2026 at 375,000 shares worth $8.47M. The position accounts for 0.2% of the portfolio, ranked #63.

C WorldWide Group first reported a position in PRCT in Q3 2025 and has held it in 4 quarters since. The position peaked at $11.8M in Q4 2025. 253 funds tracked by Wall St. Rank hold PRCT as of Q2 2026.

  • C WorldWide Group held 375,000 shares of Procept Biorobotics worth $8.47M as of Q2 2026.
  • C WorldWide Group left its Procept Biorobotics share count unchanged in Q2 2026.
  • Procept Biorobotics made up 0.2% of C WorldWide Group's portfolio in Q2 2026, its #63 holding.
  • C WorldWide Group first reported a position in Procept Biorobotics in Q3 2025 and has held it in 4 quarters since.
  • C WorldWide Group's Procept Biorobotics position peaked at $11.8M in Q4 2025.
  • 253 funds tracked by Wall St. Rank held Procept Biorobotics as of Q2 2026.

Based on C WorldWide Group's 13F filing for Q2 2026, filed 4 Aug 2026.